URI
60
-6
IPG
34
-9
A
37
-2
GILD
47
-8
ICE
59
-3
ADP
65
-3
WMB
68
2
DLTR
38
-4
VNO
46
-13
TDC
67
-4
DE
42
3
INTU
58
-3
DIS
85
3
LRCX
37
-9
RL
69
-4
OI
42
-3
DFS
64
2
D
40
2
GLW
45
-3
MO
60
-2
URI
60
-6
IPG
34
-9
A
37
-2
GILD
47
-8
ICE
59
-3
ADP
65
-3
WMB
68
2
DLTR
38
-4
VNO
46
-13
TDC
67
-4
DE
42
3
INTU
58
-3
DIS
85
3
LRCX
37
-9
RL
69
-4
OI
42
-3
DFS
64
2
D
40
2
GLW
45
-3
MO
60
-2
Financhill
Back

Arcturus Therapeutics Holdings Vs. Repligen Industry Stock Comparison

Sell
19

ARCT
Arcturus Therapeutics Holdings

Last Price:
16.02
Seasonality Move:
13.46%
Sell
30

RGEN
Repligen

Last Price:
124.90
Seasonality Move:
7.3%
Sell
19
Arcturus Therapeutics Holdings (ARCT) is a Sell

Is Arcturus Therapeutics Holdings a Buy, Sell or Hold?

  • The current Arcturus Therapeutics Holdings [ARCT] share price is $16.02. The Score for ARCT is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • ARCT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Repligen (RGEN) is a Sell

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $124.73. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARCT Stock Price Chart

What is Arcturus Therapeutics Holdings's stock price today?

  • The Arcturus Therapeutics Holdings share price today is $16.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing slight selling pressure.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $124.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

ARCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 31.24 Sell
Chaikin Money Flow: -343919 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.04 - 20.6) Sell
Bollinger Bands (100): (19.12 - 23.16) Sell

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 36.22 Sell
Chaikin Money Flow: -1285419 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (134.94 - 146.38) Sell
Bollinger Bands (100): (130 - 153.64) Sell

ARCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.77 Sell
20-day SMA: 18.89 Sell
50-day SMA: 20.51 Sell
200-day SMA: 27.13 Sell
8-day EMA: 18.36 Sell
20-day EMA: 19.07 Sell
50-day EMA: 20.23 Sell
200-day EMA: 24.34 Sell

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 142.02 Sell
20-day SMA: 140.23 Sell
50-day SMA: 141.19 Sell
200-day SMA: 157.58 Sell
8-day EMA: 139.7 Sell
20-day EMA: 140.54 Sell
50-day EMA: 141.71 Sell
200-day EMA: 151.3 Sell

Arcturus Therapeutics Holdings Earnings Growth & ARCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.71 per share.

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.

Arcturus Therapeutics Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):